Website and scientific content

The MDSGene website and database have been developed by members of the Institute of Neurogenetics (ING) and the Lübeck Interdisciplinary Platform for Genome Analytics (LIGA) at University of Lübeck (UzL), Germany. The content of MDSGene was collected in a collaborative effort by several international movement disorder research groups. Both were made possible by financial support from the Possehl foundation and the International Parkinson Disease and Movement Disorder Society .

Website design:

  • Christina M. Lill, MD, MSc (Principal Investigator; ING, UzL)
  • Ingo Zorn, MSc (ING & LIGA, UzL)
  • Lars Bertram, MD (LIGA, UzL)
  • Meike Kasten, MD (Dept. of Psychiatry, UzL)
  • Christine Klein, MD (ING, UzL)

Software development:

  • Ingo Zorn, MSc

Content creation and updates:

Parkinson’s disease

  • Jennie Hampf, MD, Institute of Neurogenetics, University of Lübeck, Lübeck, Germany
  • Meike Kasten, MD, Dept. of Psychiatry, University of Lübeck, Lübeck, Germany
  • Christine Klein, MD, Institute of Neurogenetics, University of Lübeck, Lübeck, Germany
  • Connie Marras, MD, PhD, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada

Parkinson’s disease (atypical)

  • Christina M. Lill, MD, MSc, Institute of Neurogenetics, University of Lübeck, Lübeck, Germany

Paroxysmal movement disorders

  • Darius Ebrahimi-Fakhari, MD, Center for Life Sciences, Harvard Medical School, Boston, USA

Primary brain calcification

  • Alexander Balck, MD, Institute of Neurogenetics, University of Lübeck, Lübeck, Germany
  • Ana Westenberger, PhD, Institute of Neurogenetics, University of Lübeck, Lübeck, Germany

Pathogenicity scoring

  • Katja Lohmann, PhD, Institute of Neurogenetics, University of Lübeck, Lübeck, Germany

Former team members:

  • Aloysius Domingo, MD
  • Corinna Hartmann, MD
  • Andriy Mashychev, MSc
Scientific advisory board

Kailash P. Bhatia, MD, DM, FRCP, Sobell Department for Movement Neuroscience, UCL, Institute of Neurology, Queen Square, London, United Kingdom

Susan B. Bressman, MD, Department of Neurology, Beth Israel Medical Center, New York, NY, USA

Matthew J. Farrer, PhD, Centre for Applied Neurogenetics, Djavad Mowafaghian Centre for Brain Health, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada

Marcelo Merello, MD, PhD, Movement Disorders Section, Neuroscience Department, Raul Carrea Institute for Neurological Research (FLENI), Ciudad Autónoma de Buenos Aires; Argentine National Scientific and Technological Research Council (CONICET), Buenos Aires, Argentina

Laurie J. Ozelius, PhD, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA

Eng­‐King Tan, MD, Department of Neurology, Singapore General Hospital; National Neuroscience Institute and Duke­‐NUS Graduate Medical School, Singapore